What is LivaNova's granted (in shares)?

LivaNova (LIVN) reported granted (in shares) of 957.7K in Q4 2025.

How has LivaNova's granted (in shares) changed year-over-year?

LivaNova's granted (in shares) increased by 31.3% year-over-year, from 729.5K to 957.7K.

What does granted (in shares) mean?

The total number of stock option shares granted to employees and directors during the reporting period. This metric provides insight into the company's equity-based incentive strategy and potential future dilution.

LivaNova LIVN Granted (in shares)

Granted (in shares) at other companies

Baxter InternationalBAX

1.3M—

Other financials

Income statement

See full

Revenue$362.3M+14.3%

Gross profit$243.7M+12.7%

Operating income$41.5M-14.7%

Net income$22.3M+107%

EPS (diluted)$0.40+107%

Balance sheet

See full

Cash & equivalents$539.7M-26.9%

Total debt$340.9M-49.7%

Total equity$1.2B+17.1%

Total assets$2.5B-1.7%

Cash flow

See full

Operating cash flow$15.2M-36.5%

CapEx$14.3M+32.4%

Free cash flow$926.0K-93.0%

Valuation

See full

Market cap$4.32B+62.8%

Profitability

See full

Gross margin67.5%-0.5pp

Operating margin13.4%+0.8pp

Net margin-16.1%-18.0pp

FCF margin11.2%-0.2pp

Returns & leverage

See full

Return on equity-17.6%-19.5pp

Debt / equity0.3×-0.4×

Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.

The official record: LivaNova’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's granted (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is LivaNova's granted (in shares)?: LivaNova (LIVN) reported granted (in shares) of 957.7K in Q4 2025.
How has LivaNova's granted (in shares) changed year-over-year?: LivaNova's granted (in shares) increased by 31.3% year-over-year, from 729.5K to 957.7K.
What does granted (in shares) mean?: The total number of stock option shares granted to employees and directors during the reporting period. This metric provides insight into the company's equity-based incentive strategy and potential future dilution.